Test the Waters
CureLab Veterinary, Inc.

CureLab Veterinary, Inc.

Elenavet® is poised to revolutionize cancer treatment in dogs and cats!

Claim My Business View on Wefunder
Security Type
Healthcare/Medical, Animals, Cancer, Plasmid, Vaccines
Min Investment
Amount Raised

Key Deal Facts

Using our product line, veterinarians successfully treated 10 out of 11 dogs with breast cancer.
Large Market: The US market is actively growing with pet ownership approaching 67% of households.
175 million dogs in the USA and Europe and the number is growing. 1 in 4 will develop cancer.
199 million cats in US, and Europe and the number is growing. 1 in 5 cats will develop cancer.
Elenavet also has strong potential for treating osteoarthritis, IBD, and other inflammatory mediated diseases.
80% of dogs over 7 and 90% of cats over 12 develop osteoarthritis.
Exclusive licensure of strong intellectual Property & Patents in over 20 countries.
Pet ownership provides the owner with many health benefits Elenavet hopes to help them live longer.

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter